David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
1801
DELISTED
Intersect ENT, Inc
XENT
| $3.03M | ﹤0.01% |
93,511
-43,969
| -32% | -$1.32M |
|
|
ARRY
1802
DELISTED
Array Biopharma Inc
ARRY
| $3.03M | ﹤0.01% |
236,436
+71,503
| +43% | +$813K |
|
1803
Valmont Industries
VMI
$9.21B
| $3.02M | ﹤0.01% |
18,208
-39,455
| -68% | -$6.42M |
|
|
STML
1804
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.01M | ﹤0.01% |
192,833
+105,539
| +121% | +$1.41M |
|
|
GRP.U
1805
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $3M | ﹤0.01% |
76,768
+6,100
| +9% | +$241K |
|
|
MTOR
1806
DELISTED
MERITOR, Inc.
MTOR
| $3M | ﹤0.01% |
127,944
+27,439
| +27% | +$689K |
|
1807
CALL
PACCAR
PCAR
$68B
| $3M | ﹤0.01% |
63,300
| – | – |
|
1808
PUT
Vertex Pharmaceuticals
VRTX
$139B
| $3M | ﹤0.01% |
20,000
| – | – |
|
1809
Qorvo
QRVO
$8.39B
| $2.99M | ﹤0.01% |
44,929
+32,029
| +248% | +$2.33M |
|
|
BCOV
1810
DELISTED
Brightcove, Inc.
BCOV
| $2.99M | ﹤0.01% |
420,998
+49,048
| +13% | +$355K |
|
1811
PUT
Howard Hughes
HHH
$3.92B
| $2.98M | ﹤0.01% |
23,812
+2,937
| +14% | +$350K |
|
1812
Sonida Senior Living
SNDA
$1.91B
| $2.98M | ﹤0.01% |
14,721
+2,166
| +17% | +$464K |
|
1813
CALL
W.W. Grainger
GWW
$62.9B
| $2.98M | ﹤0.01% |
12,600
-24,000
| -66% | -$4.96M |
|
1814
MKS Inc
MKSI
$18.4B
| $2.98M | ﹤0.01% |
31,484
-18,543
| -37% | -$1.85M |
|
1815
Alaska Air
ALK
$4.8B
| $2.97M | ﹤0.01% |
40,342
-90,070
| -69% | -$6.4M |
|
|
NTRI
1816
DELISTED
NutriSystem, Inc.
NTRI
| $2.97M | ﹤0.01% |
56,392
+28,830
| +105% | +$1.51M |
|
|
STKL
1817
DELISTED
SunOpta
STKL
| $2.96M | ﹤0.01% |
382,515
+6,503
| +2% | +$54.3K |
|
1818
PUT
Agnico Eagle Mines
AEM
$108B
| $2.96M | ﹤0.01% |
64,100
+38,900
| +154% | +$1.74M |
|
1819
CALL
Becton Dickinson
BDX
$51.8B
| $2.95M | ﹤0.01% |
14,145
+12,710
| +886% | +$2.66M |
|
1820
Honda
HMC
$40.8B
| $2.95M | ﹤0.01% |
86,691
-138,322
| -61% | -$4.47M |
|
1821
Natera
NTRA
$48.8B
| $2.95M | ﹤0.01% |
328,509
+53,944
| +20% | +$583K |
|
1822
Onto Innovation
ONTO
$17.8B
| $2.95M | ﹤0.01% |
118,370
+98,505
| +496% | +$2.62M |
|
1823
Radian Group
RDN
$4.87B
| $2.93M | ﹤0.01% |
142,211
-135,519
| -49% | -$2.79M |
|
|
KTWO
1824
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.92M | ﹤0.01% |
162,318
+65,329
| +67% | +$1.24M |
|
1825
CALL
CME Group
CME
$101B
| $2.92M | ﹤0.01% |
+20,000
| New | +$2.85M |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.